Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas

Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas

Recently, two cases of complete remission of classical Hodgkin lymphoma (cHL) and follicular lymphoma (FL) after SARS-CoV-2 infection were reported. However, the precise molecular mechanism of this rare event is yet to be understood. Here, we hypothesize a potential anti-tumor immune response of SAR...

Full description

Bibliographic Details
Main Authors: Debmalya Barh, Sandeep Tiwari, Lucas Gabriel Rodrigues Gomes, Marianna E. Weener, Khalid J. Alzahrani, Khalaf F. Alsharif, Alaa A. A. Aljabali, Murtaza M. Tambuwala, Kenneth Lundstrom, Sk. Sarif Hassan, Ángel Serrano-Aroca, Kazuo Takayama, Preetam Ghosh, Elrashdy M. Redwan, Bruno Silva Andrade, Siomar de Castro Soares, Vasco Azevedo, Vladimir N. Uversky
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Viruses
Subjects:
lymphoma
cancer
SARS-CoV-2
M protein
ORF3a
anti-tumor immunotherapy
Online Access:https://www.mdpi.com/1999-4915/13/10/1927

Similar Items

Similar Items